Resultats globals: 2 registres trobats en 0.03 segons.
Articles, 2 registres trobats
Articles 2 registres trobats  
1.
12 p, 2.4 MB Interim Results from the IMPACT Study : Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers / Page, Elizabeth C. (Institute of Cancer Research) ; Bancroft, Elizabeth K. (Royal Marsden NHS Foundation Trust) ; Brook, Mark N. (Institute of Cancer Research) ; Assel, Melissa (Memorial Sloan Kettering Cancer Center) ; Hassan Al Battat, Mona (Lund University) ; Thomas, Sarah (Royal Marsden NHS Foundation Trust) ; Taylor, Natalie (Royal Marsden NHS Foundation Trust) ; Chamberlain, Anthony (Institute of Cancer Research) ; Pope, Jennifer (Institute of Cancer Research) ; Raghallaigh, Holly Ni (Institute of Cancer Research) ; Evans, D.Gareth (Central Manchester University Hospitals NHS Foundation Trust) ; Rothwell, Jeanette (Central Manchester University Hospitals NHS Foundation Trust) ; Maehle, Lovise (Oslo University Hospital (Oslo, Noruega)) ; Grindedal, Eli Marie (Oslo University Hospital (Oslo, Noruega)) ; James, Paul (The Royal Melbourne Hospital) ; Mascarenhas, Lyon (Peter MacCallum Cancer Centre) ; McKinley, Joanne (Peter MacCallum Cancer Centre) ; Side, Lucy (Princess Anne Hospital) ; Thomas, Tessy (Princess Anne Hospital) ; van Asperen, Christi (Leiden University Medical Center) ; Vasen, Hans (The Foundation for the Detection of Hereditary Cancer) ; Kiemeney, Lambertus A. (Radboud University Medical Center) ; Ringelberg, Janneke (The Foundation for the Detection of Hereditary Cancer) ; Jensen, Thomas Dyrso. (Vejle Hospital) ; Osther, Palle J.S. (Vejle Hospital) ; Helfand, Brian T. (NorthShore University HealthSystem) ; Genova, Elena (NorthShore University HealthSystem) ; Oldenburg, Rogier A. (Erasmus University Medical Center) ; Cybulski, Cezary (Pomeranian Medical University in Szczecin) ; Wokolorczyk, Dominika (Pomeranian Medical University in Szczecin) ; Ong, Kai-Ren (Birmingham Women's Hospital) ; Huber, Camilla (Birmingham Women's Hospital) ; Lam, Jimmy (Bedford Park) ; Taylor, Louise (Daw Park) ; Salinas, Monica (Hospital Universitari de Bellvitge) ; Feliubadaló, Lidia (Hospital Universitari de Bellvitge) ; Oosterwijk, Jan C. (University of Groningen) ; van Zelst-Stams, Wendy (Radboud University Medical Center) ; Cook, Jackie (Sheffield Children's Hospital (Sheffield, Regne Unit)) ; Rosario, Derek J. (Royal Hallamshire Hospital) ; Domchek, Susan (Basser Research Center. University of Pennsylvania) ; Powers, Jacquelyn (University of Pennsylvania) ; Buys, Saundra (University of Utah) ; O'Toole, Karen (University of Utah) ; Ausems, Margreet G. E. M (University Medical Centre) ; Schmutzler, Rita K. (University Hospital Cologne) ; Rhiem, Kerstin (University Hospital Cologne) ; Izatt, Louise (Guy's and St Thomas' NHS Foundation Trust) ; Tripathi, Vishakha (Guy's and St Thomas' NHS Foundation Trust) ; Teixeira, Manuel R. (Porto University) ; Cardoso, Marta (Portuguese Oncology Institute (IPO Porto)) ; Foulkes, William D. (McGill University) ; Aprikian, Armen (Research Institute of McGill University Health Centre) ; van Randeraad, Heleen (The Foundation for the Detection of Hereditary Cancer) ; Davidson, Rosemarie (Queen Elizabeth University Hospital) ; Longmuir, Mark (Queen Elizabeth University Hospital) ; Ruijs, Marielle W.G. (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ; Helderman van den Enden, Apollonia T.J.M. (Maastricht University Medical Center) ; Adank, Muriel (Amsterdam UMC) ; Williams, Rachel (Prince of Wales Hospital (Australia)) ; Andrews, Lesley (Prince of Wales Hospital (Australia)) ; Murphy, Declan G. (Peter MacCallum Cancer Centre) ; Halliday, Dorothy (Oxford Centre for Genomic Medicine) ; Walker, Lisa (Oxford Centre for Genomic Medicine) ; Liljegren, Annelie (Karolinska University Hospital and Karolinska Institutet (Suecia)) ; Carlsson, Stefan (Karolinska University Hospital and Karolinska Institutet (Suecia)) ; Azzabi, Ashraf (Newcastle upon Tyne Hospitals) ; Jobson, Irene (Newcastle upon Tyne Hospitals) ; Morton, Catherine (The Royal Melbourne Hospital) ; Shackleton, Kylie (The Royal Melbourne Hospital) ; Snape, Katie (St George's Hospital) ; Hanson, Helen (St George's Hospital) ; Harris, Marion (Monash Health) ; Tischkowitz, Marc (University of Cambridge) ; Taylor, Amy (Cambridge University Hospitals NHS Trust) ; Kirk, Judy (Sydney Medical School) ; Susman, Rachel (Royal Brisbane & Women's Hospital) ; Chen-Shtoyerman, Rakefet (Kaplan Medical Center) ; Spigelman, Allan (The Kinghorn Cancer Centre. St Vincent's Hospital) ; Pachter, Nicholas (University of Western Australia) ; Ahmed, Munaza (NE Thames Regional Genetics Service) ; Ramon y Cajal, Teresa (Institut d'Investigació Biomèdica Sant Pau) ; Zgajnar, Janez (Institute of Oncology) ; Brewer, Carole (Royal Devon and Exeter Hospital) ; Gadea, Neus (Hospital Universitari Vall d'Hebron) ; Brady, Angela F. (London North West University Healthcare NHS Trust) ; van Os, Theo (Academic Medical Center) ; Gallagher, David (St James's Hospital) ; Johannsson, Oskar (Landspitali University Hospital (Reykjavík, Islàndia)) ; Donaldson, Alan (St Michael's Hospital) ; Barwell, Julian (University Hospitals Leicester) ; Nicolai, Nicola (Istituto Nazionale dei Tumori) ; Friedman, Eitan (Chaim Shema Medical Center) ; Obeid, Elias (Fox Chase Cancer Center) ; Greenhalgh, Lynn (Liverpool Women's Hospital) ; Murthy, Vedana (Tata Memorial Centre) ; Copakova, Lucia (National Cancer Institute) ; Saya, Sibel (Institute of Cancer Research) ; McGrath, John (University of Exeter Medical School) ; Cooke, Peter (New Cross Hospital) ; Rønlund, Karina (Vejle Hospital) ; Richardson, Kate (Peter MacCallum Cancer Centre) ; Henderson, Alex (West Cumberland Infirmary) ; Teo, Soo H. (Subang Jaya Medical Centre) ; Arun, Banu (The University of Texas) ; Kast, Karin (Technische Universität Dresden) ; Dias, Alexander (Instituto Nacional de Cancer Jose de Alencar Gomes da Silva (INCA)) ; Aaronson, Neil K (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ; Ardern-Jones, Audrey (Royal Marsden NHS Foundation Trust) ; Bangma, Chris H. (Erasmus University Medical Center) ; Castro, Elena (Spanish National Cancer Research Center) ; Dearnaley, David (The Institute of Cancer Research) ; Eccles, Diana M. (The University of Southampton Medical School) ; Tricker, Karen (Central Manchester University Hospitals NHS Foundation Trust) ; Eyfjord, Jorunn (University of Iceland) ; Falconer, Alison (Imperial College Healthcare NHS Trust) ; Foster, Christopher (HCA Pathology Laboratories) ; Gronberg, Henrik (University Hospital) ; Hamdy, Freddie C. (University of Oxford) ; Stefansdottir, Vigdis (Landspitali University Hospital (Reykjavík, Islàndia)) ; Khoo, Vincent (The University of Melbourne) ; Lindeman, Geoffrey J. (The Walter and Eliza Hall Institute of Medical Research) ; Lubinski, Jan (Pomeranian Medical University in Szczecin) ; Axcrona, Karol (Akershus University Hospital) ; Mikropoulos, Christos (Medway Hospital) ; Mitra, Anita (University College London Hospitals NHS Foundation Trust) ; Moynihan, Clare (Institute of Cancer Research) ; Rennert, Gadi (Carmel Medical Center) ; Suri, Mohnish (Nottingham City Hospital) ; Wilson, Penny (Innovate UK. Polaris House) ; Dudderidge, Tim (University Hospital Southampton) ; Offman, Judith (King's College London) ; Kote-Jarai, Zsofia (Institute of Cancer Research) ; Vickers, Andrew (Memorial Sloan Kettering Cancer Center) ; Lilja, Hans (Memorial Sloan-Kettering Cancer Center (Nova York, Estats Units d'Amèrica)) ; Eeles, Rosalind A. (Royal Marsden NHS Foundation Trust) ; Universitat Autònoma de Barcelona
Mutations in BRCA2 cause a higher risk of early-onset aggressive prostate cancer (PrCa). The IMPACT study is evaluating targeted PrCa screening using prostate-specific-antigen (PSA) in men with germline BRCA1/2 mutations. [...]
2019 - 10.1016/j.eururo.2019.08.019
European Urology, Vol. 76 Núm. 6 (december 2019) , p. 831-842  
2.
14 p, 1007.9 KB A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT) : initial results from an international prospective study / Bancroft, Elizabeth K. (Royal Marsden NHS Foundation Trust, London) ; Page, Elizabeth C. (Institute of Cancer Research, London) ; Brook, Mark N. (Institute of Cancer Research, London) ; Thomas, Sarah (Royal Marsden NHS Foundation Trust, London) ; Taylor, Natalie (Royal Marsden NHS Foundation Trust, London) ; Pope, Jennifer (Institute of Cancer Research, London) ; McHugh, Jana (Institute of Cancer Research, London) ; Jones, Ann-Britt (Institute of Cancer Research, London) ; Karlsson, Questa (Institute of Cancer Research, London) ; Merson, Susan (Institute of Cancer Research, London) ; Ong, Kai Ren (Birmingham Women's Hospital) ; Hoffman, Jonathan (Birmingham Women's Hospital) ; Huber, Camilla (Birmingham Women's Hospital) ; Maehle, Lovise (Oslo University Hospital (Oslo, Noruega)) ; Grindedal, Eli Marie (Oslo University Hospital (Oslo, Noruega)) ; Stormorken, Astrid (Oslo University Hospital (Oslo, Noruega)) ; Evans, D. Gareth (University of Mancheste) ; Rothwell, Jeanette (University of Manchester) ; Lalloo, Fiona (University of Manchester) ; Brady, Angela F. (London North West University Healthcare NHS Trust, Harrow) ; Bartlett, Marion (London North West University Healthcare NHS Trust, Harrow) ; Snape, Katie (St George's Hospital, Tooting, London) ; Hanson, Helen (St George's Hospital, Tooting, London) ; James, Paul (The University of Melbourne) ; McKinley, Joanne (Parkville Familial Cancer Centre, Melbourne) ; Mascarenhas, Lyon (Parkville Familial Cancer Centre, Melbourne) ; Syngal, Sapna (Brigham and Women's Hospital (Boston, Estats Units d'Amèrica)) ; Ukaegbu, Chinedu (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Side, Lucy (Wessex Princess Anne Hospital, Southampton) ; Thomas, Tessy (Princess Anne Hospital, Southampton) ; Barwell, Julian (University Hospitals Leicester, Leicester) ; Teixeira, Manuel R. (Porto University, Porto) ; Izatt, Louise (Guy's and St Thomas' NHS Foundation Trust, London) ; Suri, Mohnish (Nottingham University Hospitals NHS Trust (Regne Unit)) ; Macrae, Finlay A. (Royal Melbourne Hospital (Melbourne, Austràlia)) ; Poplawski, Nicola (University of Adelaide, Adelaide) ; Chen-Shtoyerman, Rakefet (Ariel University, Ariel) ; Ahmed, Munaza (Institute of Child Health, London) ; Musgrave, Hannah (Leeds Teaching Hospitals NHS Trust, Leeds) ; Nicolai, Nicola (Fondazione IRCCS Istituto Nazionale dei Tumori, Milano) ; Greenhalgh, Lynn (Clinical Genetics Service, Liverpool Women's Hospital, Liverpool) ; Brewer, Carole (Royal Devon & Exeter Hospital (Exeter, Regne Unit)) ; Pachter, Nicholas (University of Western Australia, Perth) ; Spigelman, Allan D. (St Vincent's Hospital (Sydney)) ; Azzabi, Ashraf (Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne) ; Helfand, Brian T. (NorthShore University HealthSystem, Evanston) ; Halliday, Dorothy (Oxford University Hospitals NHS Trust) ; Buys, Saundra (University of Utah, Salt Lake City) ; Ramon y Cajal, Teresa (Institut d'Investigació Biomèdica Sant Pau) ; Donaldson, Alan (St Michael's Hospital, Bristol) ; Cooney, Kathleen A. (Duke Cancer Institute and Duke University School of Medicine, Durham) ; Harris, Marion (Monash University, Clayton) ; McGrath, John (University of Exeter Medical School, Exeter) ; Davidson, Rosemarie (Queen Elizabeth University Hospital, Glasgow) ; Taylor, Amy (Cambridge University Hospitals NHS Foundation Trust (Regne Unit)) ; Cooke, Peter (New Cross Hospital, Wolverhampton, UK) ; Myhill, Kathryn (Royal Marsden NHS Foundation Trust, London) ; Hogben, Matthew (Royal Marsden NHS Foundation Trust, London) ; Aaronson, Neil K. (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ; Ardern-Jones, Audrey (Royal Marsden NHS Foundation Trust, London) ; Bangma, Chris H. (Erasmus Cancer Institute, Rotterdam) ; Castro, Elena (Spanish National Cancer Research Center, Madrid) ; Dearnaley, David (The Institute of Cancer Research, Sutton) ; Dias, Alexander (Instituto Nacional de Cancer Jose de Alencar Gomes da Silva INCA, Rio de Janeiro) ; Dudderidge, Tim (University Hospital Southampton) ; Eccles, Diana M. (University of Southampton, Southampton) ; Green, Kate (University of Manchester, Manchester) ; Eyfjord, Jorunn (University of Iceland, Reykjavik) ; Falconer, Alison (Imperial College Healthcare NHS Trust, London) ; Foster, Christopher S. (HCA Pathology Laboratories, London) ; Gronberg, Henrik (University Hospital of Umeå) ; Hamdy, Freddie C. (University of Oxford) ; Johannsson, Oskar (Landspitali University Hospital (Reykjavík, Islàndia)) ; Khoo, Vincent (The Institute of Cancer Research, Sutton, Surrey) ; Lilja, Hans (Department of Laboratory Medicine, Memorial Sloan-Kettering Cancer Center, New York) ; Lindeman, Geoffrey J. (The Walter and Eliza Hall Institute of Medical Research, Parkville) ; Lubinski, Jan (Pomeranian Medical University in Szczecin) ; Axcrona, Karol (Department of Urology, Akershus University Hospital, Lørenskog) ; Mikropoulos, Christos (Royal Surrey County Hospital, Guildford) ; Mitra, Anita V (University College London Hospitals NHS Foundation Trust, London) ; Moynihan, Clare (Institute of Cancer Research, London) ; Ni Raghallaigh, Holly (Institute of Cancer Research, London) ; Rennert, Gad (CHS National Cancer Control Center, Haifa) ; Collier, Rebecca (Nottingham University Hospitals NHS Trust (Regne Unit)) ; Offman, Judith (King's College London) ; Kote-Jarai, Zsofia (Institute of Cancer Research) ; Eeles, Rosalind A. (Royal Marsden NHS Foundation Trust, London) ; Universitat Autònoma de Barcelona
Lynch syndrome is a rare familial cancer syndrome caused by pathogenic variants in the mismatch repair genes MLH1, MSH2, MSH6, or PMS2, that cause predisposition to various cancers, predominantly colorectal and endometrial cancer. [...]
2021 - 10.1016/S1470-2045(21)00522-2
The Lancet. Oncology, Vol. 22 (november 2021) , p. 1618-1631  

Vegeu també: autors amb noms similars
3 Thomas, T.
1 Thomas, Tegos
1 Thomas, Tim
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.